written by reader “The Biggest Breakthrough Since Insulin.”

By ruthmain, March 23, 2015

Brian Tycangco (in ”Asian Growth Stocks”) sees a tiny biotech company eliminating the need for insulin injections for diabetics. The company is also working on Parkinson’s and other ”un-touchable” diseases by developing the ability to insert foreign cells into a person’s body without an immune reaction. Is this one of those too-good-to-be-true speculations, or is it worth at least a small investment?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
John Mantz
John Mantz
March 27, 2015 2:09 am
Reply to  ruthmain

The company is Living Cell Technologies. The website is http://www.lctglobal.com

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info